Fulgent Genetics (NASDAQ:FLGT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Fulgent Genetics beat estimated earnings by 6.85%, reporting an EPS of $0.78 versus an estimate of $0.73.
Revenue was down $28.27 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.22 which was followed by a 3.6% increase in the share price the next day.
Here’s a look at Fulgent Genetics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 3.86 | 2.61 | 3.25 | 2.81 |
| EPS Actual | 5.08 | 3.48 | 4.05 | 2.55 |
| Revenue Estimate | 270.85M | 191.10M | 264.00M | 197.34M |
| Revenue Actual | 320.27M | 251.67M | 227.87M | 153.62M |
To track all earnings releases for Fulgent Genetics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
